Using CluePoints?
Make sure your team is ready to get value from it.
RBQM platforms detect risk. BleuConsult makes sure your team can act on it — with the SOPs, governance, and decision pathways that turn signals into inspection-ready, defensible outcomes.
The gap most teams hit
A RBQM platform is only as valuable as the operational foundation it sits on. Without readiness, detection becomes noise:
Readiness, then the platform
BleuConsult is the advisory and readiness layer that makes your RBQM platform work.
1. Assess readiness
Take our 10-dimension Clinical Operations Intelligence Readiness Assessment. We score your data, governance, decision owners, and escalation pathways — and tell you honestly whether a platform will produce value yet.
2. Build the foundation
We deliver the SOPs, forms, trackers, and governance structure your platform's outputs flow through — aligned to ICH E6(R3) and 21 CFR Part 11 — so signals route to a named owner with a documented action path.
3. Launch with your platform
With the foundation in place, your RBQM platform produces inspection-ready, defensible outcomes instead of orphan alerts. BleuConsult stays on as advisory support for the judgment calls a tool cannot make.
Detects risk signals in your trial data — central statistical monitoring, site scoring, query detection. Assumes your data, governance, and decision owners are already in place.
Builds the operational foundation — readiness, SOPs, governance, escalation pathways — and provides the human judgment that determines whether a signal is clinically meaningful and operationally actionable.
Together: detection plus the decision pathway that makes it inspection-ready. Many teams use both — BleuConsult first to build the foundation, then the platform to monitor at scale.
What BleuConsult delivers
BleuConsult is an independent clinical operations advisory firm and is not affiliated with, endorsed by, or a reseller of CluePoints, Medidata, Veeva, or Cyntegrity.
Compliance & Transparency
oPoS is an advisory decision-support tool designed to assist clinical trial planning. It does not replace professional regulatory judgment. The methodology is designed to support ICH E6(R3)-aligned assessment, sponsor oversight documentation, and decision evidence. The platform may process business contact information, uploaded protocol materials, and other user-provided content. Do not upload PHI unless appropriate agreements and safeguards are in place. VeriAbyss™ provides AI-assisted consistency review; outputs remain advisory until qualified human review.
© 2026 BleuConsult. All methodologies, frameworks, assessment logic, and library materials are the proprietary intellectual property of BleuConsult. All rights reserved.
All assessments are for informational purposes only.
